Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery: An International Prospective Cohort Study

Farima Dalaei; Phillip J Dijkhorst; Sören Möller; Anne F Klassen; Claire E E de Vries; Lotte Poulsen; Manraj N Kaur; Jørn Bo Thomsen; Maarten Hoogbergen; Sophocles H Voineskos; Jussi P Repo; Jakub Opyrchal; Marek Adam Paul; Kay-Hendrik Busch; Annalisa Cogliandro; Michael Rose; Stefan J Cano; Andrea L Pusic; Jens A Sørensen

doi:10.1093/asj/sjae162

Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery: An International Prospective Cohort Study

Farima Dalaei^*, Phillip J Dijkhorst, Sören Möller, Anne F Klassen, Claire E E de Vries, Lotte Poulsen, Manraj N Kaur, Jørn Bo Thomsen, Maarten Hoogbergen, Sophocles H Voineskos, Jussi P Repo, Jakub Opyrchal, Marek Adam Paul, Kay-Hendrik Busch, Annalisa Cogliandro, Michael Rose, Stefan J Cano, Andrea L Pusic, Jens A Sørensen

^*Corresponding author af dette arbejde

Plastik- og Brystkirurgisk Afdeling

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Abstract

BACKGROUND: The BODY-Q is a widely used patient-reported outcome measure for comprehensive assessment of treatment outcomes specific to patients undergoing body contouring surgery (BCS). However, for the BODY-Q to be meaningfully interpreted and used in clinical practice, minimal important difference (MID) scores are needed. A MID is defined as the smallest change in outcome measure score that patients perceive as important.

OBJECTIVES: The aim of this study was to determine BODY-Q MID estimates for patients undergoing BCS to enhance the interpretability of the BODY-Q.

METHODS: Data from an international, prospective cohort from Denmark, Finland, Germany, Italy, the Netherlands, and Poland were included. Two distribution-based methods were used to estimate MID: 0.2 standard deviations of mean baseline scores and the mean standardized response change of BODY-Q scores from baseline to 3 years postoperatively.

RESULTS: A total of 12,554 assessments from 3237 participants (mean age 42.5 ± 9.3 years; BMI 28.9 ± 4.9 kg/m2) were included. Baseline MID scores ranged from 1 to 5 on the health-related quality of life (HRQL) scales and 3 to 6 on the appearance scales. The estimated MID scores from baseline to 3-year follow-up ranged from 4 to 5 for HRQL and from 4 to 8 on the appearance scales.

CONCLUSIONS: The BODY-Q MID estimates from before BCS to 3 years postoperatively ranged from 4 to 8 and are recommended for interpretation of patients' BODY-Q scores, evaluation of treatment effects of different BCS procedures, and calculation of sample size for future studies.

Originalsprog	Engelsk
Sider (fra-til)	1317-1329
Antal sider	13
Tidsskrift	Aesthetic Surgery Journal
Vol/bind	44
Udgave nummer	12
Tidlig onlinedato	23 jul. 2024
DOI	https://doi.org/10.1093/asj/sjae162
Status	Udgivet - 15 nov. 2024

Bibliografisk note

Adgang til dokumentet

10.1093/asj/sjae162

Citationsformater

Dalaei, F., Dijkhorst, P. J., Möller, S., Klassen, A. F., de Vries, C. E. E., Poulsen, L., Kaur, M. N., Thomsen, J. B., Hoogbergen, M., Voineskos, S. H., Repo, J. P., Opyrchal, J., Paul, M. A., Busch, K.-H., Cogliandro, A., Rose, M., Cano, S. J., Pusic, A. L., & Sørensen, J. A. (2024). Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery: An International Prospective Cohort Study. Aesthetic Surgery Journal, 44(12), 1317-1329. https://doi.org/10.1093/asj/sjae162

@article{2118ac765eb145cfbc91cb13e0229408,

title = "Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery: An International Prospective Cohort Study",

abstract = "BACKGROUND: The BODY-Q is a widely used patient-reported outcome measure for comprehensive assessment of treatment outcomes specific to patients undergoing body contouring surgery (BCS). However, for the BODY-Q to be meaningfully interpreted and used in clinical practice, minimal important difference (MID) scores are needed. A MID is defined as the smallest change in outcome measure score that patients perceive as important.OBJECTIVES: The aim of this study was to determine BODY-Q MID estimates for patients undergoing BCS to enhance the interpretability of the BODY-Q.METHODS: Data from an international, prospective cohort from Denmark, Finland, Germany, Italy, the Netherlands, and Poland were included. Two distribution-based methods were used to estimate MID: 0.2 standard deviations of mean baseline scores and the mean standardized response change of BODY-Q scores from baseline to 3 years postoperatively.RESULTS: A total of 12,554 assessments from 3237 participants (mean age 42.5 ± 9.3 years; BMI 28.9 ± 4.9 kg/m2) were included. Baseline MID scores ranged from 1 to 5 on the health-related quality of life (HRQL) scales and 3 to 6 on the appearance scales. The estimated MID scores from baseline to 3-year follow-up ranged from 4 to 5 for HRQL and from 4 to 8 on the appearance scales.CONCLUSIONS: The BODY-Q MID estimates from before BCS to 3 years postoperatively ranged from 4 to 8 and are recommended for interpretation of patients' BODY-Q scores, evaluation of treatment effects of different BCS procedures, and calculation of sample size for future studies.",

keywords = "Adult, Body Contouring/methods, Body Image/psychology, Female, Humans, Male, Middle Aged, Minimal Clinically Important Difference, Patient Reported Outcome Measures, Patient Satisfaction/statistics & numerical data, Prospective Studies, Quality of Life, Treatment Outcome",

author = "Farima Dalaei and Dijkhorst, {Phillip J} and S{\"o}ren M{\"o}ller and Klassen, {Anne F} and {de Vries}, {Claire E E} and Lotte Poulsen and Kaur, {Manraj N} and Thomsen, {J{\o}rn Bo} and Maarten Hoogbergen and Voineskos, {Sophocles H} and Repo, {Jussi P} and Jakub Opyrchal and Paul, {Marek Adam} and Kay-Hendrik Busch and Annalisa Cogliandro and Michael Rose and Cano, {Stefan J} and Pusic, {Andrea L} and S{\o}rensen, {Jens A}",

note = "{\textcopyright} The Author(s) 2024. Published by Oxford University Press on behalf of The Aesthetic Society.",

year = "2024",

month = nov,

day = "15",

doi = "10.1093/asj/sjae162",

language = "English",

volume = "44",

pages = "1317--1329",

journal = "Aesthetic Surgery Journal",

issn = "1090-820X",

publisher = "Oxford University Press",

number = "12",

}

Dalaei, F, Dijkhorst, PJ, Möller, S, Klassen, AF, de Vries, CEE, Poulsen, L, Kaur, MN, Thomsen, JB, Hoogbergen, M, Voineskos, SH, Repo, JP, Opyrchal, J, Paul, MA, Busch, K-H, Cogliandro, A, Rose, M, Cano, SJ, Pusic, AL & Sørensen, JA 2024, 'Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery: An International Prospective Cohort Study', Aesthetic Surgery Journal, bind 44, nr. 12, s. 1317-1329. https://doi.org/10.1093/asj/sjae162

TY - JOUR

T1 - Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery

T2 - An International Prospective Cohort Study

AU - Dalaei, Farima

AU - Dijkhorst, Phillip J

AU - Möller, Sören

AU - Klassen, Anne F

AU - de Vries, Claire E E

AU - Poulsen, Lotte

AU - Kaur, Manraj N

AU - Thomsen, Jørn Bo

AU - Hoogbergen, Maarten

AU - Voineskos, Sophocles H

AU - Repo, Jussi P

AU - Opyrchal, Jakub

AU - Paul, Marek Adam

AU - Busch, Kay-Hendrik

AU - Cogliandro, Annalisa

AU - Rose, Michael

AU - Cano, Stefan J

AU - Pusic, Andrea L

AU - Sørensen, Jens A

N1 - © The Author(s) 2024. Published by Oxford University Press on behalf of The Aesthetic Society.

PY - 2024/11/15

Y1 - 2024/11/15

N2 - BACKGROUND: The BODY-Q is a widely used patient-reported outcome measure for comprehensive assessment of treatment outcomes specific to patients undergoing body contouring surgery (BCS). However, for the BODY-Q to be meaningfully interpreted and used in clinical practice, minimal important difference (MID) scores are needed. A MID is defined as the smallest change in outcome measure score that patients perceive as important.OBJECTIVES: The aim of this study was to determine BODY-Q MID estimates for patients undergoing BCS to enhance the interpretability of the BODY-Q.METHODS: Data from an international, prospective cohort from Denmark, Finland, Germany, Italy, the Netherlands, and Poland were included. Two distribution-based methods were used to estimate MID: 0.2 standard deviations of mean baseline scores and the mean standardized response change of BODY-Q scores from baseline to 3 years postoperatively.RESULTS: A total of 12,554 assessments from 3237 participants (mean age 42.5 ± 9.3 years; BMI 28.9 ± 4.9 kg/m2) were included. Baseline MID scores ranged from 1 to 5 on the health-related quality of life (HRQL) scales and 3 to 6 on the appearance scales. The estimated MID scores from baseline to 3-year follow-up ranged from 4 to 5 for HRQL and from 4 to 8 on the appearance scales.CONCLUSIONS: The BODY-Q MID estimates from before BCS to 3 years postoperatively ranged from 4 to 8 and are recommended for interpretation of patients' BODY-Q scores, evaluation of treatment effects of different BCS procedures, and calculation of sample size for future studies.

AB - BACKGROUND: The BODY-Q is a widely used patient-reported outcome measure for comprehensive assessment of treatment outcomes specific to patients undergoing body contouring surgery (BCS). However, for the BODY-Q to be meaningfully interpreted and used in clinical practice, minimal important difference (MID) scores are needed. A MID is defined as the smallest change in outcome measure score that patients perceive as important.OBJECTIVES: The aim of this study was to determine BODY-Q MID estimates for patients undergoing BCS to enhance the interpretability of the BODY-Q.METHODS: Data from an international, prospective cohort from Denmark, Finland, Germany, Italy, the Netherlands, and Poland were included. Two distribution-based methods were used to estimate MID: 0.2 standard deviations of mean baseline scores and the mean standardized response change of BODY-Q scores from baseline to 3 years postoperatively.RESULTS: A total of 12,554 assessments from 3237 participants (mean age 42.5 ± 9.3 years; BMI 28.9 ± 4.9 kg/m2) were included. Baseline MID scores ranged from 1 to 5 on the health-related quality of life (HRQL) scales and 3 to 6 on the appearance scales. The estimated MID scores from baseline to 3-year follow-up ranged from 4 to 5 for HRQL and from 4 to 8 on the appearance scales.CONCLUSIONS: The BODY-Q MID estimates from before BCS to 3 years postoperatively ranged from 4 to 8 and are recommended for interpretation of patients' BODY-Q scores, evaluation of treatment effects of different BCS procedures, and calculation of sample size for future studies.

KW - Adult

KW - Body Contouring/methods

KW - Body Image/psychology

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Minimal Clinically Important Difference

KW - Patient Reported Outcome Measures

KW - Patient Satisfaction/statistics & numerical data

KW - Prospective Studies

KW - Quality of Life

KW - Treatment Outcome

U2 - 10.1093/asj/sjae162

DO - 10.1093/asj/sjae162

M3 - Article

C2 - 39041862

SN - 1090-820X

VL - 44

SP - 1317

EP - 1329

JO - Aesthetic Surgery Journal

JF - Aesthetic Surgery Journal

IS - 12

ER -

Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery: An International Prospective Cohort Study

Abstract

Bibliografisk note

Adgang til dokumentet

Fingeraftryk

Citationsformater